Therapy of localized non-small cell lung cancer

Lung Cancer

Volumn 33, Issue SUPPL. 1, 2001, Pages

  Baumann, Michael ^a   Stamatis, Georgios ^b   Thomas, Michael ^c  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b RUHRLANDKLINIK   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Localized stages; Non small cell lung cancer; Treatment

Indexed keywords

ADJUVANT; CISPLATIN;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CLINICAL TRIAL; HUMAN; LUNG NON SMALL CELL CANCER; METASTASIS; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT;

EID: 0034833383     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(01)00302-6     Document Type: Article

References (5)

1. Preoperative staging of non-small-cell lung cancer with positron emission tomography
2. Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implication
3. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials
4. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from 9 randomised controlled trials
5. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: a randomised multicentre trial